HIP REPLACEMENT SURGERY (ARTHROPLASTY)

Similar documents
Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

OTHER AND UNSPECIFIED DISORDERS

Solid Organ Transplant Benefits to Change for Texas Medicaid

Folotyn (pralatrexate)

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

Cardiac Rehabilitation Services

CLINICAL MEDICAL POLICY

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers

Related Policies None

Original Policy Date

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)

Fee Schedule - Home Health Care- 2015

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers

Original Date: December 2015 Page 1 of 8 FOR CMS (MEDICARE) MEMBERS ONLY

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO

Drug Therapy Guidelines

Indications and Limitations of Coverage and/or Medical back to top

o Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

Itay Perets, MD Lyall Ashberg, MD Edwin O. Chaharbakhshi, BS, John P. Walsh, MA Mary R. Close, BS Benjamin G. Domb, MD. Hinsdale Orthopaedics

Rituxan (rituximab) Effective Date: 10/01/2015. Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018

2017 CMS Web Interface

Drug Therapy Guidelines

Anterior Total Hip Arthroplasty Patient Guide & Common Questions

Benefits to Change for Diagnostic and Surgical/Reconstructive Breast Therapies and Corrective Procedures January 1, 2016

Instructions for Use Reprocessed Non Sterile External Fixation Devices

Erythropoiesis Stimulating Agents (ESAs): Aranesp (darbepoetin alfa) Related Medical Guideline Off-Label Use of FDA-Approved Drugs and Biologicals

International Myeloma Working Group Guidelines on Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma 1

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

2016 CWA Political Action Fund Administrative Procedures Checklist

MRI LOWER EXTREMITIES IMAGING FACT SHEET. MRI Lower Extremities

MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache

PODIATRY Delineation of Clinical Privileges

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning

Ontario s Referral and Listing Criteria for Adult Lung Transplantation

2017 CMS Web Interface

For Commercial products, please refer to the following policy: Preauthorization via Web-Based Tool for Procedures

Updates to Medical Policies and Clinical UM Guidelines Effective January 15, 2012

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

SPINRAZA (NUSINERSEN)

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

MIDLAND MEMORIAL HOSPITAL Delineation of Privileges ORTHOPEDIC SURGERY

Diabetes Mellitus Lab Tests (Screening, Diagnosis & Monitoring)

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit.

Obesity/Morbid Obesity/BMI

UNM SRMC SLEEP MEDICINE CLINICAL PRIVILEGES.

o Prostanoids/prostacyclin therapies (oral and inhaled) o Inhaled agents: Ventavis, Tyvaso Page 1 of 5 Revised 02/17/17

Physical Fitness for the Physically Limited. o Work Experience, General. o Open Entry/Exit. Distance (Hybrid Online) for online supported courses

A foot x-ray series is required only if there is pain in the midfoot zone and any one of the following:

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

Structured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information

cerliponase alfa (Brineura )

Methadone Maintenance Treatment for Opioid Dependence

Guideline Number: NIA_CG_301 Last Revised Date: October 2014 Responsible Department: Implementation Date: October 2014 Clinical Operations

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10

FDA Dietary Supplement cgmp

Immunisation and Disease Prevention Policy

Clinical Policy: Vedolizumab (Entyvio) Reference Number: ERX.SPA.163 Effective Date:

A Unified Approach to Conflict Mineral Compliance for the Tungsten Industry. The Westin, Sydney, 23 September 2013

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH

Corporate Governance Code for Funds: What Will it Mean?

SCALES NW HEARING PROTECTION PROGRAM

2017 CMS Web Interface

2017 CMS Web Interface

Guideline Number: NIA_CG_302 Last Revised Date: September 2015 Responsible Department: Implementation Date: September 2015 Clinical Operations

Breast Surgery Corporate Medical Policy

2018 CMS Web Interface

Mylotarg (gemtuzumab ozogamicin) (Intravenous)

Page 1 of 5. Fast Facts. CTC v.4; AJCC 7 th ed. Herceptin provided

Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid

EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL

Nutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will:

Subject: Panniculectomy/Removal of Redundant Skin and Subcutaneous Tissue

2018 CMS Web Interface

Meeting the Nutritional Requirements of Individuals with Dementia

ADVANCED IMAGING CLINICAL APPROPRIATENESS GUIDELINES. Appropriate Use Criteria: Imaging of the Extremities. EFFECTIVE JANUARY 1, 2019 Proprietary

SANTIS Pedicle Screw System Please read carefully INSTRUCTIONS FOR USE

Documentation Requirements for LL Prosthetics

DISTRIBUTION: ORGANIZATION WIDE APPROVED BY: VP COMPLIANCE

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.

This standard operating procedure applies to stop smoking services provided by North 51.

Page New: Ophthalmologic Policy - Vascular Endothelial Growth Factor (VEGF) - Effective May 1,

ITP typically presents with the sudden appearance of a petechial rash, spontaneous bruising and/or bleeding in an otherwise well child.

Specifically, on page 12 of the current evicore draft, we find the statement:

Perjeta (pertuzumab) Document Number: IC I. Length of Authorization. Dosing Limits. Initial Approval Criteria

Commissioning Policy: South Warwickshire CCG (SWCCG)

TEXAS-MAC - PART B-TRAILBLAZER TABLE OF CONTENTS

Drug Therapy Guidelines

Drug Therapy Guidelines

Imaging tests allow the cancer care team to check for cancer and other problems inside the body.

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

All indications: 60 billable units every 6 months. Giant Cell Tumor of Bone; Hypercalcemia of malignancy

Kent and Medway Policy Recommendation and Guidance Committee Policy Recommendation

Sunny Smiles Pediatric Dentistry

Transcription:

Prtcl: ORT015 Effective Date: June 1, 2017 HIP REPLACEMENT SURGERY (ARTHROPLASTY) Table f Cntents Page COMMERCIAL & MEDICAID COVERAGE RATIONALE... 1 MEDICARE COVERAGE RATIONALE... 3 U.S.FOOD AND DRUG ADMINISTRATION (FDA)... 4 APPLICABLE CODES... 5 PROTOCOL HISTORY/REVISION INFORMATION... 5 INSTRUCTIONS FOR USE This prtcl prvides assistance in interpreting UnitedHealthcare benefit plans. When deciding cverage, the enrllee specific dcument must be referenced. The terms f an enrllee's dcument (e.g., Certificate f Cverage (COC) r Evidence f Cverage (EOC)) may differ greatly. In the event f a cnflict, the enrllee's specific benefit dcument supersedes this prtcl. All reviewers must first identify enrllee eligibility, any federal r state regulatry requirements and the plan benefit cverage prir t use f this Prtcl. Other Prtcls, Plicies and Cverage Determinatin Guidelines may apply. UnitedHealthcare reserves the right, in its sle discretin, t mdify its Prtcls, Plicies and Guidelines as necessary. This prtcl is prvided fr infrmatinal purpses. It des nt cnstitute medical advice. This plicy des nt gvern Medicare Grup Retiree members. UnitedHealthcare may als use tls develped by third parties, such as the MCG Care Guidelines, t assist us in administering health benefits. The MCG Care Guidelines are intended t be used in cnnectin with the independent prfessinal medical judgment f a qualified health care prvider and d nt cnstitute the practice f medicine r medical advice. COMMERCIAL & MEDICAID COVERAGE RATIONALE Fr infrmatin regarding medical necessity review, when applicable, see MCG Care Guidelines, 21st Editin, 2017Hip Arthrplasty, S-560 (ISC), accessed April 2017. MCG Care Guidelines: Hip Arthrplasty, S-560 Clinical Indicatins fr Prcedure: Prcedure is indicated fr 1 r mre f the fllwing: Degenerative jint disease as indicated by ALL f the fllwing: Presence f significant radigraphic findings (eg, hip jint destructin, severe narrwing, bne defrmities, stenecrsis) Optimal medical management has been tried and failed (eg, analgesics, NSAIDs, physical therapy) Patient has failed r is nt a candidate fr mre cnservative measures (eg, stetmy, hemiarthrplasty) Hip Replacement Surgery (Arthrplasty) Page 1 f 6

Treatment is needed because f 1 r mre f the fllwing: Disabling pain Functinal disability Primary and secndary tumrs invlving the prximal femur Ostenecrsis f femral head Develpmental dysplasia f hip Displaced fracture f the femral neck in a patient withut significant cgnitive impairment Acetabular fracture Pertrchanteric fracture and 1 r mre f the fllwing: Ipsilateral hip stearthritis Ipsilateral avascular necrsis f the femral head Inflammatry arthritis Cmminuted, significantly displaced, r unstable fracture Pr bne quality (eg, thin crtices, wide intramedullary canal n imaging) Cmplicatin f internal fixatin Neglected fracture Failed previus hip fracture fixatin Revisin f hip arthrdesis Revisin f previus arthrplasty r resurfacing indicated by 1 r mre f the fllwing: Instability f ne r bth cmpnents Fracture r mechanical failure f the implant Recurrent r irreducible dislcatin Infectin Treatment f a periprsthetic fracture Tissue r systemic reactin t metal implant Leg-length inequality **End f MCG Fr infrmatin regarding medical necessity review, when applicable, see MCG Care Guidelines, 21st Editin, 2017, Hip: Displaced Fracture f Femral Neck, Hemiarthrplasty, S-600 (ISC), accessed April 2017. MCG Care Guidelines: Hip: Displaced Fracture f Femral Neck, Hemiarthrplasty, S-600 (ISC) Clinical Indicatins fr Prcedure Prcedure is indicated fr 1 r mre f the fllwing: Displaced fracture f femral neck in lder patient (eg, 65 years r lder) Fracture-dislcatin f hip in lder patient (eg, 65 years r lder) Reductin r fixatin f hip fracture that cannt be maintained Recent histry f failed fixatin f femral neck fracture Fracture f neck f femur with cmplete dislcatin f femral head Fracture superimpsed upn pre-existing lesins f hip (eg, radiatin changes, severe arthritis) Fracture f femral neck in patient with psychsis r severe cgnitive impairment Pathlgic fracture f femral neck Pertrchanteric fracture and 1 r mre f the fllwing: Hip Replacement Surgery (Arthrplasty) Page 2 f 6

Ipsilateral hip stearthritis Ipsilateral avascular necrsis f the femral head Inflammatry arthritis Cmminuted, significantly displaced, r unstable fracture Pr bne quality (eg, thin crtices, wide intramedullary canal n imaging) Cmplicatin f internal fixatin Neglected fracture ***End f MCG MEDICARE COVERAGE RATIONALE Medicare des nt have a Natinal Cverage Determinatin, but des have a Lcal Cverage Determinatin fr Nevada fr Ttal Jint Arthrplasty (L34163) (Accessed April 2017). Ttal Jint Arthrplasty (L34163) Ttal Hip Arthrplasty (THA) Ttal hip replacement surgery is medically necessary when ne r mre f the fllwing criteria* are met: Advanced jint disease demnstrated by: Radigraphic supprted evidence r when cnventinal radigraphy is nt adequate, magnetic resnance imaging (MRI) supprted evidence (subchndral cysts, subchndral sclersis, periarticular stephytes, jint subluxatin, jint space narrwing, avascular necrsis); and Pain that cannt be adequately cntrlled despite ptimal cnservative treatment r functinal disability frm injury due t trauma r arthritis f the jint); and If apprpriate, histry f unsuccessful cnservative therapy (nn-surgical medical management) that is clearly addressed in the pre prcedure medical recrd. (If cnservative therapy is nt apprpriate, the medical recrd must clearly dcument the ratinale fr why such apprach is nt reasnable); r Malignancy f the jint invlving the bnes r sft tissues f the pelvis r prximal femur; r Avascular necrsis (stenecrsis f femral head); r Fracture f the femral neck; r Acetabular fracture; r Nn-unin r failure f previus hip fracture surgery; r Mal-unin f acetabular r prximal femur fracture *See Assciated Infrmatin Dcumentatin Requirements fr additinal infrmatin. Nn-surgical medical management is usually but nt always implemented prir t scheduling ttal jint surgery. Nn-surgical treatment as clinically apprpriate fr the patient s current episde f care typically includes ne r mre f the fllwing: anti-inflammatry medicatins r analgesics, r flexibility and muscle strengthening exercises, r supervised physical therapy [Activities f daily living (ADLs) diminished despite cmpleting a plan f care], r assistive device use, r Hip Replacement Surgery (Arthrplasty) Page 3 f 6

weight reductin as apprpriate, r therapeutic injectins int the hip as apprpriate. Indicatins fr Replacement/Revisin f Ttal Hip Arthrplasty Lsening f ne r bth cmpnents; r Fracture r mechanical failure f the implant; r Recurrent r irreducible dislcatin; r Infectin; r Treatment f a displaced periprsthetic fracture; r Clinically significant leg length inequality nt amenable t cnservative management; r Prgressive r substantial bne lss; r Bearing surface wear leading t symptmatic synvitis r lcal bne r sft tissue reactin; r Clinically significant audible nise; r Adverse lcal tissue reactin Limitatins Ttal knee replacement r ttal hip replacement is nt medically necessary when the fllwing cntraindicatins are present: Active infectin f the hip r knee jint r active systemic bacteremia Active skin infectin (exceptin recurrent cutaneus staph infectins) r pen wund within the planned surgical site f the hip r knee Rapidly prgressive neurlgical disease except in the clinical situatin f a cncmitant displaced femral neck fracture The fllwing cnditins are relative cntraindicatins t ttal knee r ttal hip replacement and if such surgery is perfrmed in the presence f these cnditins, it is expected that the ratinale fr prceeding with the surgery under such circumstances is clearly dcumented in the medical recrd: Absence r relative insufficiency f abductr musculature Any prcess that is rapidly destrying bne Neurtrphic arthritis Fr Medicare and Medicaid Determinatins Related t States Outside f Nevada: Please review Lcal Cverage Determinatins that apply t ther states utside f Nevada. http://www.cms.hhs.gv/mcd/search Imprtant Nte: Please als review lcal carrier Web sites in additin t the Medicare Cverage database n the Centers fr Medicare and Medicaid Services Website. U.S.FOOD AND DRUG ADMINISTRATION (FDA) Hip replacement surgery is a prcedure and therefre is nt regulated by the FDA. Hwever, devices and instruments used during the surgery require FDA apprval. Several devices have FDA apprval. Additinal infrmatin (prduct cde MEH, JDI, JDG, LWJ, LPH, LZO, KWY, KWA) is available at: http://www.accessdata.fda.gv/scripts/cdrh/devicesatfda/index.cfm. Accessed April 2017. Hip Replacement Surgery (Arthrplasty) Page 4 f 6

The FDA-apprved ttal hip arthrplasty (THA) devices are generally apprved fr the same indicatins, including any r all f the fllwing: Severe hip pain and disability due t stearthritis (OA), rheumatid arthritis (RA), traumatic arthritis (TA), plyarthritis, cllagen disrders, avascular necrsis f the femral head, r nnunin f prir femral fracture. Cngenital hip dysplasia, prtrusia acetabuli (bulging f the femral head int the pelvis), r slipped capital femral epiphysis. Disability due t previus fusin. Acute femral neck fracture. APPLICABLE CODES The fllwing list(s) f prcedure and/r diagnsis cdes is prvided fr reference purpses nly and may nt be all inclusive. Listing f a cde in this plicy des nt imply that the service described by the cde is a cvered r nn- cvered health service. Benefit cverage fr health services is determined by the member specific benefit plan dcument and applicable laws that may require cverage fr a specific service. The inclusin f a cde des nt imply any right t reimbursement r guarantee claim payment. Other Plicies and Cverage Determinatin Guidelines may apply. CPT Cdes Descriptin 27120 Acetabulplasty; (e.g., Whitman, Clnna, Haygrves, r cup type) 27122 Acetabulplasty; resectin, femral head (e.g., Girdlestne prcedure) 27125 Hemiarthrplasty, hip, partial (e.g., femral stem prsthesis, biplar arthrplasty) 27130 Arthrplasty, acetabular and prximal femral prsthetic replacement (ttal hip arthrplasty), with r withut autgraft r allgraft 27132 Cnversin f previus hip surgery t ttal hip arthrplasty, with r withut autgraft r allgraft 27134 Revisin f ttal hip arthrplasty; bth cmpnents, with r withut autgraft r allgraft 27137 Revisin f ttal hip arthrplasty; acetabular cmpnent nly, with r withut autgraft r allgraft 27138 Hip Revisin f ttal hip arthrplasty; femral cmpnent nly, with r withut allgraft CPT is a registered trademark f the American Medical Assciatin PROTOCOL HISTORY/REVISION INFORMATION Date 04/27/2017 04/28/2016 06/25/2015 09/25/2014 05/22/2014 12/19/2013 02/28/2013 Actin/Descriptin Crprate Medical Affairs Cmmittee Hip Replacement Surgery (Arthrplasty) Page 5 f 6

04/26/2012 02/23/2012 The freging Health Plan f Nevada/Sierra Health & Life Health Operatins prtcl has been adpted frm an existing UnitedHealthcare cverage determinatin guideline that was researched, develped and apprved by the UnitedHealthcare Cverage Determinatin Cmmittee. Hip Replacement Surgery (Arthrplasty) Page 6 f 6